Novo Nordisk ' s Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China

Novo Nordisk A/S NVO has reportedly warned, indicating that starter kits for its widely used diabetes drug Ozempic (semaglutide) will not be available in Germany during the second quarter. This scarcity in Europe, attributed to the drug’s weight-reducing effects, persists, as outlined in a…#novonordiskasnvo #novo #novonordisk #ozempic #wegovy #novonordisksozempic #novosozempic #dkk48billion #jiuyuangene #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news